Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study

被引:0
|
作者
Kohji Shirai
Toru Fujita
Michitaka Tanaka
Yuka Fujii
Masatsugu Shimomasuda
Soichi Sakai
Yoshishige Samukawa
机构
[1] Mihama Hospital,Department of Internal Medicine
[2] Taisho Pharmaceutical Co.,undefined
[3] Ltd.,undefined
来源
Advances in Therapy | 2019年 / 36卷
关键词
Body weight; Double-blind; Efficacy; Japanese; Lipase inhibitor; Obesity; Orlistat; Placebo-controlled; Randomized; Safety; Visceral fat; Waist circumference;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:86 / 100
页数:14
相关论文
共 50 条
  • [1] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study
    Shirai, Kohji
    Fujita, Toru
    Tanaka, Michitaka
    Fujii, Yuka
    Shimomasuda, Masatsugu
    Sakai, Soichi
    Samukawa, Yoshishige
    [J]. ADVANCES IN THERAPY, 2019, 36 (01) : 86 - 100
  • [2] A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer's Disease
    Nakamura, Yu
    Imai, Yukimichi
    Shigeta, Masahiro
    Graf, Ana
    Shirahase, Toru
    Kim, Hyosung
    Fujii, Akifumi
    Mori, Joji
    Homma, Akira
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 163 - 179
  • [3] Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study
    Simpson, Richard W.
    Nicholson, Geoffrey C.
    Proietto, Joseph
    Sarah, Alana
    Sanders, Kerrie M.
    Phillips, Gabrielle
    Chambers, Jo
    MacGinley, Rob
    Orford, Neil
    Walder, Ken
    Krippner, Guy
    Skoff, Kathy
    Wacher, Vincent J.
    [J]. DIABETES CARE, 2014, 37 (11) : 3121 - 3123
  • [4] Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia
    Bashir, Mustafa
    Paredes, Angelo
    Frias, Juan
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristen
    Gottwald, Mildred
    Chang, William
    Yan, Andrew
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S617 - S617
  • [5] Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Bolliger, Chris T.
    Issa, Jaqueline S.
    Posadas-Valay, Rodolfo
    Safwat, Tarek
    Abreu, Paula
    Correia, Eurico A.
    Park, Peter W.
    Chopra, Pravin
    [J]. CLINICAL THERAPEUTICS, 2011, 33 (04) : 465 - 477
  • [6] EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY
    Allanore, Y.
    Wung, P.
    Soubrane, C.
    Esperet, C.
    Frederic, M.
    Bejuit, R.
    Lahmar, A.
    Khanna, D.
    Denton, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 157 - 158
  • [7] Efficacy and Safety of Romilkimab in Diffuse Cutaneous Systemic Sclerosis (dcSSc): A Randomized, Double-Blind, Placebo-Controlled, 24-week, Proof of Concept Study
    Allanore, Yannick
    Denton, Christopher
    Khanna, Dinesh
    Soubrane, Christina
    Esperet, Corinne
    Marrache, Frederic
    Bejuit, Raphael
    Lahmar, Amel
    Wung, Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Efficacy and safety of canagliflozin rnonotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study
    Inagaki, Nobuya
    Kondo, Kazuoki
    Yoshinari, Toru
    Takahashi, Nahoko
    Susuta, Yutaka
    Kuki, Hideki
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1501 - 1515
  • [9] A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder
    Montgomery, SA
    Nil, R
    Dürr-Pal, N
    Loft, H
    Boulenger, JP
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1270 - 1278
  • [10] LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282)
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia D.
    Bashir, Mustafa
    Frias, Juan Pablo
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristin
    Gottwald, Mildred
    Chang, William
    Yan, Andrew Z.
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen A.
    [J]. HEPATOLOGY, 2020, 72 : 1022 - 1023